Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Halozyme Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
HALO
Nasdaq
2834
https://www.halozyme.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Halozyme Therapeutics, Inc.
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
- May 16th, 2024 6:55 pm
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
- May 16th, 2024 1:45 pm
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
- May 15th, 2024 1:40 pm
Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
- May 10th, 2024 4:39 pm
The 3 Best Biotech Stocks to Buy in May 2024
- May 9th, 2024 10:15 am
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
- May 8th, 2024 7:10 pm
Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates
- May 8th, 2024 2:34 pm
Halozyme to Participate in Upcoming Investor Conferences
- May 8th, 2024 12:30 pm
Q1 2024 Halozyme Therapeutics Inc Earnings Call
- May 8th, 2024 11:05 am
Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
- May 8th, 2024 7:52 am
Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- May 7th, 2024 10:00 pm
Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
- May 7th, 2024 9:49 pm
Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
- May 7th, 2024 9:25 pm
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS
- May 7th, 2024 8:01 pm
Halozyme Therapeutics (HALO) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
- May 6th, 2024 1:16 pm
How Novo-Catalent Deal Affects Halozyme (HALO)?
- May 3rd, 2024 8:17 am
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
- Apr 30th, 2024 2:01 pm
Mahesh Krishnan Elected to Halozyme's Board of Directors
- Apr 25th, 2024 8:45 pm
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
- Apr 25th, 2024 10:00 am
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
- Apr 24th, 2024 1:45 pm
Scroll